The RAGE axis and endothelial dysfunction: Maladaptive roles in the diabetic vasculature and beyond

Trends in Cardiovascular Medicine

Volumn 15, Issue 7, 2005, Pages 237-243

  Ramasamy, Ravichandran ^a   Shi, Fang Yan ^a   Schmidt, Ann Marie ^a  

^a NewYork Presbyterian Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT; AMYLOID BETA PROTEIN; CALGRANULIN; CARDIOVASCULAR AGENT; CD11B ANTIGEN; CELL SURFACE IMMUNOGLOBULIN; GLUCOSE; HIGH MOBILITY GROUP B1 PROTEIN; PROTEIN S 100;

ATHEROSCLEROSIS; BLOOD VESSEL INJURY; BLOOD VESSEL PERMEABILITY; CARDIOVASCULAR DISEASE; CELL CULTURE; CELLULAR PARAMETERS; DIABETES MELLITUS; DRUG TARGETING; ENDOTHELIUM CELL; ENDOTHELIUM LESION; EXPERIMENTATION; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN VERSUS ANIMAL COMPARISON; IN VIVO STUDY; INFLAMMATION; INTIMA; MOLECULAR MECHANICS; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN FUNCTION; RECEPTOR UPREGULATION; REVIEW; SIGNAL TRANSDUCTION; VASCULAR DISEASE; VASCULARIZATION;

ANIMALS; ARTERIOSCLEROSIS; DIABETES COMPLICATIONS; DIABETES MELLITUS; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; INFLAMMATION; LIGANDS; MUSCLE, SMOOTH; RECEPTORS, IMMUNOLOGIC; VASCULAR DISEASES;

EID: 26444436438     PISSN: 10501738     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tcm.2005.08.003     Document Type: Review

References (51)

1. N Ahmed, and PJ Thorn alley Quantitative screening of protein biomarkers of early gyration, advanced gyration, oxidation and intonation in cellular and extracellular proteins by tandem mass spectrometry multiple reaction monitoring Biochem Soc Trans 31 2003 1417 1422
2. Y Aso, T Iuka, K Tehama, and Y Taciturn Serum concentrations of advanced glycation endproducts are associated with the development of atherosclerosis as well as diabetic microangiopathy in patients with type 2 diabetes Acta Diabetol 37 2000 87 92
3. G Basta, G Lazzerini, and S Del Turco At least two pathways generating reactive oxygen species mediate vascular cell adhesion molecule-1 induction by advanced glycation endproducts Arterioscler Thromb Vasc Biol 25 2005 1401 1407
4. WK Bolton, DC Cattran, and ME Williams Randomized trial of an inhibitor of formation of advanced glycation endproducts in diabetic nephropathy Am J Nephrol 24 2004 32 40
5. LG Bucciarelli, T Wendt, and W Qu RAGE blockade stabilizes established atherosclerosis in diabetic apolipoprotein E null mice Circulation 106 2002 2827 2835
6. T Chavakis, A Bierhaus, and N Al-Fakhri The pattern recognition receptor (RAGE) is a counter receptor for leukocyte integrins: A novel pathway for inflammatory cell recruitment J Exp Med 198 2003 1507 1515
7. Y Chen, SS Yan, and J Colgan Blockade of late stages of autoimmune diabetes by inhibition of the receptor for advanced glycation end products J Immunol 173 2004 1399 1405
8. F Cipollone, A Iezzi, and M Fazia The receptor RAGE as a progression factor amplifying arachidonate-dependent inflammatory and proteolytic response in human atherosclerotic plaques: Role of glycemic control Circulation 108 2003 1070 1077
9. C Falcone, I Campo, and E Emanuele Relationship between the -374 T/A RAGE gene polymorphism and angiographic coronary artery disease Int J Mol Med 14 2004 1061 1064
10. C Falcone, I Campo, and E Emanuele The -374 T/A polymorphism of the RAGE gene promoter in relation to severity of coronary atherosclerosis Clin Chim Acta 354 2005 111 116
11. C Falcone, E Emanuele, and A D'Angelo Plasma levels of soluble receptor for advanced glycation endproducts and coronary artery disease in nondiabetic men Arterioscler Thromb Vasc Biol 25 2005 1032 1037
12. M Frosch, A Strey, and T Vogl Myeloid-related proteins 8 and 14 are specifically secreted during interaction of phagocytes and activated endothelium and are useful markers for monitoring disease activity in pauciarticular-onset juvenile rheumatoid arthritis Arthritis Rheum 43 2000 628 637
13. MA Hofmann, S Drury, and C Fu RAGE mediates a novel proinflammatory axis: A central cell surface receptor for S100/calgranulin polypeptides Cell 97 1999 889 901
14. MA Hofmann, S Drury, and BI Hudson RAGE and arthritis: The G82S polymorphism amplifies the inflammatory response Genes Immun 3 2002 123 135
15. O Hori, J Brett, and T Slattery The receptor for advanced glycation endproducts (RAGE) is a cellular binding site for amphoterin: Mediation of neurite outgrowth and co-expression of RAGE and amphoterin in the developing nervous system J Biol Chem 270 1995 25752 25761
16. JS Huang, JY Guh, and HC Chen Role of receptor for advanced glycation endproducts (RAGE) and the Jak/Stat-signaling pathway in AGE-induced collagen production in NRK-49F cells J Cell Biochem 81 2001 102 113
17. BI Hudson, MH Stickland, TS Futers, and PJ Grant Study of the -429T/C and -374T/A receptor for advanced glycation end products polymorphisms in diabetic and nondiabetic subjects with macrovascular disease Diabetes Care 24 2001 2004
18. HJ Huttunen, C Fages, and H Rauvala Receptor for advanced glycation endproducts (RAGE)-mediated neurite outgrowth and activation of NF-κB require the cytoplasmic domain of the receptor but different downstream signaling pathways J Biol Chem 294 1999 19919 19924
19. M Kanauchi, N Tsujimoto, and T Hashimoto Advanced glycation endproducts in nondiabetic patients with coronary artery disease Diabetes Care 24 2001 1620 1623
20. WB Kannel, and DL McGee Diabetes and cardiovascular disease: The Framingham Study JAMA 241 1979 2035 2038
21. DA Kass, EP Shapiro, and M Kawaguchi Improved arterial compliance by a novel advanced glycation endproduct crosslink breaker Circulation 104 2001 1464 1470
22. J Kirbis, A Milutinovic, and K Steblovnik The -429 T/C and -374 T/A gene polymorphisms of the receptor for advanced glycation endproducts gene (RAGE) are not risk factors for coronary artery disease in Slovene population with type 2 diabetes Coll Antropol 28 2004 611 616
23. T Kislinger, C Fu, and B Huber Nε (carboxymethyl)lysine modifications of proteins are ligands for RAGE that activate cell signaling pathways and modulate gene expression J Biol Chem 274 1999 31740 31749
24. T Kislinger, N Tanji, and T Wendt RAGE mediates inflammation and enhanced expression of tissue factor in the vasculature of diabetic apolipoprotein E null mice Arterioscler Thromb Vasc Biol 21 2001 905 910
25. T Kitauchi, K Yoshida, and T Yoneda Association between pentosidine levels and arteriosclerosis in patients receiving hemodialysis Clin Exp Nephrol 8 2004 48 53
26. HL Lander, JM Tauras, and JS Ogiste Activation of the receptor for advanced glycation end products triggers a MAP kinase pathway regulated by oxidant stress J Biol Chem 272 1997 17810 17814
27. J Li, and AM Schmidt Characterization and functional analysis of the promoter of RAGE, the receptor for advanced glycation endproducts J Biol Chem 272 1997 16498 16506
28. WC Little, MR Zile, and DW Kitzman The effect of alagebrium chloride (ALT-711), a novel glucose cross-link breaker, in the treatment of elderly patients with diastolic heart failure J Card Fail 11 2005 191 195
29. LC Maillard Formation d'humus et de combustibles minéraux sans intervention de l'oxygène atmosphérique, des micro-organismes, des hautes températures ou fortes pressions C R Acad Sci 154 1912 1554 1556
30. DM Nathan, J Lachin, and P Cleary Intensive diabetes therapy and carotid intima-media thickness in type 1 diabetes N Engl J Med 348 2003 2294 2303
31. M Neeper, AM Schmidt, and J Brett Cloning and expression of RAGE: A cell surface receptor for advanced glycosylation end products of proteins J Biol Chem 267 1992 14998 15004
32. L Park, KG Raman, and KJ Lee Suppression of accelerated diabetic atherosclerosis by soluble receptor for AGE (sRAGE) Nat Med 4 1998 1025 1031
33. K Petersson-Fernholm, C Forsblom, and BI Hudson The functional -374 T/A RAGE gene polymorphism is associated with proteinuria and cardiovascular disease in type 1 diabetic patients Diabetes 52 2003 891 894
34. S Rahbar, O Blumenfeld, and HM Ranney Studies of an unusual hemoglobin in patients with diabetes mellitus Biochem Biophys Res Commun 36 1969 838 843
35. A Rammes, J Roth, and M Goebeler Myeloid-related protein (MRP) 8 and MRP14, calcium-binding proteins of the S100 family, are secreted by activated monocytes via a novel, tubulin-dependent pathway J Biol Chem 272 1997 9496 9502
36. LL Rong, SF Yan, and T Wendt RAGE modulates peripheral nerve regeneration via recruitment of both inflammatory and axonal outgrowth pathways FASEB J 18 2004 1818 1825
37. T Sakaguchi, SF Yan, and SD Yan Arterial restenosis: Central role of RAGE-dependent neointimal expansion J Clin Invest 111 2003 959 972
38. AM Schmidt, M Vianna, and M Gerlach Isolation and characterization of binding proteins for advanced glycosylation endproducts from lung tissue which are present on the endothelial cell surface J Biol Chem 267 1992 14987 14997
39. IM Stratton, AI Adler, and HA Neil Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): Prospective observational study BMJ 321 2000 405 412
40. A Taguchi, DC Blood, and G Del Toro Blockade of amphoterin/RAGE signalling suppresses tumor growth and metastases Nature 405 2000 354 360
41. The Diabetes Control and Complications Trial Research Group The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin dependent diabetes mellitus N Engl J Med 329 1993 977 986
42. UK Prospective Diabetes Study (UKPDS) Group Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes Lancet 352 1998 837 853
43. H Vlassara, H Fuh, and T Donnelly Advanced glycation endproducts promote adhesion molecule (VCAM-1, ICAM-1) expression and atheroma formation in normal rabbits Mol Med 1 1995 447 456
44. H Wang, O Bloom, and M Zhang HMG-1 as a late mediator of endotoxin lethality in mice Science 285 1999 248 251
45. JL Wautier, and AM Schmidt Protein glycation: A firm link to endothelial cell dysfunction Circ Res 95 2004 233 238
46. JL Wautier, RC Paton, and MP Wautier Increased adhesion of erythrocytes to endothelial cells in diabetes mellitus and its relation to vascular complications N Engl J Med 305 1981 237 242
47. JL Wautier, MP Wautier, and AM Schmidt Advanced glycation end products (AGEs) on the surface of diabetic erythrocytes bind to the vessel wall via a specific receptor inducing oxidant stress in the vasculature: A link between surface-associated AGEs and diabetic complications Proc Natl Acad Sci U S A 91 1994 7742 7746
48. JL Wautier, C Zoukourian, and O Chappey Receptor-mediated endothelial cell dysfunction in diabetic vasculopathy. Soluble receptor for advanced glycation endproducts blocks hyperpermeability in diabetic rats J Clin Invest 97 1996 238 243
49. MP Wautier, O Chappey, and S Corda Activation of NADPH oxidase by advanced glycation endproducts (AGEs) links oxidant stress to altered gene expression via RAGE Am J Physiol 280 2001 E685 E694
50. SSD Yan, ZY Wu, and HP Zhang Suppression of experimental autoimmune encephalomyelitis by selective blockade of encephalitogenic T-cell infiltration of the central nervous system Nat Med 9 2003 287 293
51. Z Zhou, K Wang, and MS Penn Receptor for AGE (RAGE) mediates neointimal formation in response to arterial injury Circulation 107 2003 2238 2243